Department of Clinical Sciences Lund, Division of Nephrology, Lund University, Sweden.
Department Nephrology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain.
Nephrol Dial Transplant. 2024 Aug 30;39(9):1483-1493. doi: 10.1093/ndt/gfae018.
Kidney involvement is common in anti-neutrophil cytoplasm antibody-associated vasculitis (AAV) and the prognosis is determined by the severity of kidney damage. This study focused on long-term kidney outcomes, defining possible risk factors and comparing the performance of three different histological classifications to predict outcomes for patients with AAV.
The dataset included 848 patients with newly diagnosed AAV who participated in seven randomized controlled trials (RCTs) (1995-2012). Follow-up information was obtained from questionnaires sent to the principal investigators of the original RCTs.
The cumulative incidence of end-stage kidney disease (ESKD) at 5 and 10 years was 17% and 22%, respectively. Patients who developed ESKD had reduced patient survival compared with those with preserved kidney function (hazard ratio 2.8, P < .001). Comparing patients with AAV and kidney involvement with a matched general population, patients with AAV had poor survival outcomes, even in early stages of chronic kidney disease. The main cause of death was infection followed by cardiovascular disease in patients developing ESKD and malignancy in those who did not. Some 34% of patients with initial need for dialysis recovered kidney function after treatment. Thirty-five out of 175 in need of kidney replacement therapy (KRT) during follow-up received a kidney transplant with good outcome; there was 86% patient survival at 10 years.In the subcohort of 214 patients with available kidney biopsies, three scoring systems were tested: the Berden classification, the Renal Risk Score and the Mayo Clinic Score. The scores highlighted the importance of normal glomeruli and severe glomerulosclerosis on kidney survival (P < .001 and P = .001, respectively). The Renal Risk Score demonstrated a moderate prediction of kidney survival (area under the curve 0.79; standard error 0.03, 95% confidence interval 0.71-0.83).
Early diagnosis of AAV is extremely important. Even milder forms of kidney involvement have an impact on the prognosis. Patients in need of KRT had the lowest survival rates, but kidney transplantation has shown favorable outcomes for eligible AAV patients. The three histologic scoring systems were all identified as independent prognostic factors for kidney outcome.
抗中性粒细胞胞浆抗体相关性血管炎(AAV)常累及肾脏,其预后取决于肾脏损伤的严重程度。本研究聚焦于长期肾脏结局,确定可能的危险因素,并比较三种不同的组织学分类方法预测 AAV 患者的结局。
该数据集纳入了 848 例新诊断的 AAV 患者,他们参加了 7 项随机对照试验(RCT)(1995-2012 年)。随访信息通过向原始 RCT 的主要研究者发送调查问卷获得。
5 年和 10 年时,终末期肾病(ESKD)的累积发生率分别为 17%和 22%。与保留肾功能的患者相比,发生 ESKD 的患者的患者生存率降低(风险比 2.8,P<.001)。与匹配的一般人群相比,有肾脏受累的 AAV 患者的生存结局较差,即使在慢性肾脏病的早期阶段也是如此。ESKD 患者死亡的主要原因是感染,其次是心血管疾病,而未发生 ESKD 的患者则是恶性肿瘤。初始需要透析的患者中,约 34%在治疗后恢复了肾功能。在随访期间需要肾脏替代治疗(KRT)的 175 例患者中有 35 例接受了肾脏移植,且预后良好;10 年时患者生存率为 86%。在有可用肾活检标本的 214 例亚组患者中,测试了三种评分系统:Berden 分类、肾脏风险评分和 Mayo 诊所评分。评分结果突出了正常肾小球和严重肾小球硬化对肾脏生存的重要性(P<.001 和 P=.001)。肾脏风险评分对肾脏生存有中度预测能力(曲线下面积 0.79;标准误差 0.03,95%置信区间 0.71-0.83)。
早期诊断 AAV 极为重要。即使是较轻的肾脏受累形式也会影响预后。需要 KRT 的患者的生存率最低,但肾脏移植已显示出对适合的 AAV 患者有利的结局。三种组织学评分系统均被确定为肾脏结局的独立预后因素。